[Infliximab treatment of severe bleeding complicating Crohn's disease].
Julián Gómez
L
L
Atienza
R
R
Barrio
J
J
Gil
P
P
Gómez de la Cuesta
S
S
Pinto
P
P
Alcaide
N
N
Caro Patón
A
A
D015746:Abdominal Pain / Q000209:etiology; D000038:Abscess / Q000209:etiology; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003082:Colectomy; D003093:Colitis, Ulcerative / Q000601:surgery; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D006471:Gastrointestinal Hemorrhage / Q000209:etiology*; D006801:Humans; D007081:Ileostomy; D000069285:Infliximab; D008297:Male; D008532:Megacolon, Toxic / Q000209:etiology / Q000601:surgery; D011183:Postoperative Complications / Q000209:etiology / Q000601:surgery; D012086:Reoperation; D014456:Ulcer / Q000209:etiology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab